The Additive Clinical Value of 18F-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels
Clinical Nuclear Medicine , 07/16/2012
Ozkan E et al. – Isolated increased antithyroglobulin antibody (TgAb) levels might be a predictor of the recurrent DTC and 18F–FDG PET/CT might be an additive imaging method in detecting the recurrent disease in patients with differentiated thyroid cancer (DTC) who have increased TgAb levels with undetectable thyroglobulin (Tg) levels and negative 131I wbs.



